![David Schenkein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Schenkein
Directeur/Membre du Conseil chez
DENALI THERAPEUTICS INC.
Fortune : 2 M $ au 31/05/2026
Profil
Dr. David P.
Schenkein, MD, is an Independent Director at Regeneron Pharmaceuticals, Inc., an Independent Director at Prime Medicine, Inc., a General Partner at GV Management Co. LLC and an Independent Director at Denali Therapeutics, Inc. He is on the Board of Directors at Regeneron Pharmaceuticals, Inc., Prime Medicine, Inc., Denali Therapeutics, Inc., Biotechnology Innovation Organization, Transcend Therapeutics, Inc. (New York), Treeline Biosciences, Inc. and Leyden Laboratories BV.
Dr. Schenkein was previously employed as an Independent Director by bluebird bio, Inc., an Independent Director by Blueprint Medicines Corp., an Independent Director by Foundation Medicine, Inc., an Independent Director by Agios Pharmaceuticals, Inc., a Senior Vice President-Oncology Development by Genentech, Inc., a Senior Vice President-Clinical Research by Takeda Oncology Co., a Venture Partner by ARCH Venture Partners LLC, and an Associate Professor by Tufts Medical Center, Inc. He also served on the board at bluebird bio Inc /Private Group/.
He received his undergraduate degree from Wesleyan University and a doctorate degree from SUNY Upstate Medical University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DENALI THERAPEUTICS INC. 0,05 % | 03/06/2026 | 79 129 ( 0,05 % ) | 2 M $ | 31/05/2026 |
| 14/04/2026 | 516 ( 0 % ) | 317 226 $ | 31/05/2026 | |
PRIME MEDICINE, INC. -.--% | 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de David Schenkein
| Sociétés | Poste | Début |
|---|---|---|
| DENALI THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/04/2015 |
| PRIME MEDICINE, INC. | Directeur/Membre du Conseil | 13/09/2019 |
| REGENERON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/09/2023 |
Transcend Therapeutics
 Transcend Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage, neuroscience-focused company that develops rapid-acting treatments for neuropsychiatric diseases | Directeur/Membre du Conseil | - |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Develops molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates for cancer, autoimmune and neurological diseases | Directeur/Membre du Conseil | - |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses | Directeur/Membre du Conseil | - |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance Google Ventures invests in companies located in North America, Europe and Israel. The firm focuses on companies operating in the fields of technology and life sciences sectors. It provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | 01/02/2019 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | 01/01/2012 |
Anciens postes connus de David Schenkein
| Sociétés | Poste | Fin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Directeur Général | 01/02/2019 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de David Schenkein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts Medical Center, Inc.
 Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
GV Management Co. LLC
GV Management Co. LLC Investment ManagersFinance Google Ventures invests in companies located in North America, Europe and Israel. The firm focuses on companies operating in the fields of technology and life sciences sectors. It provides financing for seed, early and growth stage capital requirements. | Finance |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Leyden Laboratories B.V.
Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses | Health Technology |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Develops molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates for cancer, autoimmune and neurological diseases | Health Technology |
Transcend Therapeutics
Transcend Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage, neuroscience-focused company that develops rapid-acting treatments for neuropsychiatric diseases | Health Technology |
